LEARN MORE Bringing personalized care in Radiation Oncology towards ‘’minimum-achievable-risk’’ radiotherapy Every medical practice exhibits some degree of uncertainty. This is inevitably true in the case of Radiation Oncology. A technology enabling the minimization of such uncertainty results in safer and more effective treatments.

The core mission of RTsafe from its establishment was to develop and commercialize such technologies, enabling personalized care in radiation oncology, aiming for ‘’minimum-achievable-risk’’ radiotherapy.
LEARN MORE REQUEST A QUOTE
FOLLOW OUR EASY 5 STEPS TO BUILD YOUR PHANTOM

Personalized care in Radiation Oncology

During the first six years of its operations, RTsafe has focused mainly on brain cancer. PseudoPatient, nominated as one of the 100 most technologically significant products in 2019, is the personalized care solution that RTsafe has developed, patented and commercialized for brain tumor patients, following extensive R&D and tens of scientific publications. It is a 510k-FDA cleared solution that is already improving the lives of patients globally in a totally personalized way.

Our next core milestones are to make our personalized care solutions easily accessible to millions of cancer patients globally and to keep innovating and developing equivalent solutions for cancer types other than brain tumors.

At RTsafe, our goal is to develop and implement high-end technologies to achieve maximum treatment efficiency combined with maximum patient safety, allowing the patient to return to life’s activities, following an effective treatment.

Whatever role you play in the treatment cycle, RTsafe’s products and services can help you. Click on the button below to learn more about the benefits we can bring to you and your colleagues.

Find out how RTsafe can help you

Lorem Ipsum is simply dummy text of the printing and typesetting industry.

Learn how our technology changes the way
you work.

Lorem Ipsum is simply dummy text of theprinting and typesetting industry.

Learn how our technology changes the way
you work.

Lorem Ipsum is simply dummy text of theprinting and typesetting industry.

Learn how our technology changes the way
you work.

The PseudoPatient® solution

Play Video

See what's new at RTsafe

RTsafe receives grant under the Operational Program “Competitiveness, Entrepreneurship & Innovation” (EPAnEK), €100,000.00.

RTsafe receives grant under the Operational Program “Competitiveness, Entrepreneurship & Innovation” (EPAnEK), €100,000.00.

Announcements
Η RTsafe χρηματοδοτείται στο πλαίσιο του Επιχειρησιακού Προγράμματος «Ανταγωνιστικότητα, Επιχειρηματικότητα και Καινοτομία (ΕΠΑνΕΚ), μέσω της δράσης «Στήριξη Νεοφυών Επιχειρήσεων Εθνικού...
Read More
PseudoPatient Technology – A personalized pretreatment verification in SRS

PseudoPatient Technology – A personalized pretreatment verification in SRS

Announcements
Join our Webinar on September 28, 1:00 p.m. UK by Dr Georgios Kritselis, titled ‘’PseudoPatient Technology - A personalized pretreatment...
Read More
RTsafe and Biomedic Medical Group sign exclusive agreement for distribution

RTsafe and Biomedic Medical Group sign exclusive agreement for distribution

Announcements
RTsafe, a medical technology company focused on improving the safety and accuracy of radiotherapy for cancer and other medical conditions,...
Read More

Testimonials

Download our complete
product cataloque.

Request a quote

End Users

Customers Placeholder
Customers
ΕΣΠΑ Banner